United States

People: Sol Gel Technologies Ltd (SLGL.OQ)

SLGL.OQ on NASDAQ Stock Exchange Global Market

23 Aug 2019
Change (% chg)

$0.30 (+3.70%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Seri-Levy, Alon 

Dr. Alon Seri-Levy is Chief Executive Officer, Co-Founder, Director of the Company. He co-founded Sol-Gel and has served as our chief executive officer since our inception in 1997 and as a member of our board of directors until 2014. Prior to founding Sol-Gel, Dr. Seri-Levy established the computer-aided drug design department at Peptor Ltd., an Israeli research and development company that specialized in the development of peptide-based drug products. Dr. Seri-Levy holds a Ph.D. in Chemistry (summa cum laude) from The Hebrew University of Jerusalem, Israel, and conducted his post-doctoral studies at Oxford University, United Kingdom. Dr. Seri-Levy was appointed to our board of directors immediately following the pricing of this offering.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --